title: Relapsing brucellosis after liver transplantation in a child: what is the appropriate regimen and duration of therapy?
authors.forename: Ali
authors.initials: A
authors.lastname: Islek
authors.forename: Ersin
authors.initials: E
authors.lastname: Sayar
authors.forename: Aygen
authors.initials: A
authors.lastname: Yilmaz
authors.forename: Filiz
authors.initials: F
authors.lastname: Günseren
authors.forename: Reha
authors.initials: R
authors.lastname: Artan
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000008:administration & dosage; D002006:Brucellosis / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D016031:Liver Transplantation; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D011183:Postoperative Complications / Q000188:drug therapy* / Q000209:etiology* / Q000382:microbiology; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage*
chemical_list: D000890:Anti-Infective Agents; D000995:Antitubercular Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D012293:Rifampin